Multiple Sclerosis Updates

Let's win this battle together! This blog aims to explain as simply as possible the latest advances in the fight against Multiple Sclerosis, a poorly understood disease. We hope to help patients and others interested in learning about MS. Read, comment and share. The author, Dr. Ratna Mirchandani, a researcher and teacher, lives in Chennai after relocating from the US. She has a passion for helping MS patients. She is a member of the Chennai Chapter of the MS Society of India.

Thursday, March 4, 2010

Fingolimod ( Gilenia) By Novartis

›
Novartis has come up with oral therapy of MS. This is Gilenia ( Fingolimod; FTY 720). I had reported earlier in my blog about these Chinese...
Tuesday, March 2, 2010

MS not autoimmune but vascular disease

›
Dr. Paolo Zamboni (Professor of Medicine, Univ. of Ferrara, Italy) has made a breakthrough by changing the basic understanding of MS. MS is...
Friday, December 18, 2009

Review of Transfer Factor for MS

›
Recently, I completed a review of descriptions of Transfer Factor. Here's my summary: Resources Reviewed: 1. Two NIH papers on clinical ...
1 comment:
Tuesday, December 15, 2009

Results of Phase II Trials by Novartis of FTY 720 (fingolimod)

›
1. A Phase II clinical trial involves a larger group of people ( 20- 300) to know how well the drug works and also to continue to test the...
2 comments:
Monday, December 14, 2009

Isaria sinclairii / FTY720 ( fingolimod) - A Chinese "medicine" for Multiple Sclerosis

›
This fungus grows on insects and devours them. It belongs to a group of fungi commonly called ' vegetable wasps and plant worms'. Sp...
Friday, June 26, 2009

Dr. Ratna Mirchandani's research in one post

›
It's always a challenge to summarize one's research for a lay audience, but without this, we risk being guilty of not communicating....
1 comment:
Home
View web version
Powered by Blogger.